ES2196381T3 - Comprimidos chupables para liberacion modificada de principios activos en el tracto gastrointestinal. - Google Patents
Comprimidos chupables para liberacion modificada de principios activos en el tracto gastrointestinal.Info
- Publication number
- ES2196381T3 ES2196381T3 ES97950197T ES97950197T ES2196381T3 ES 2196381 T3 ES2196381 T3 ES 2196381T3 ES 97950197 T ES97950197 T ES 97950197T ES 97950197 T ES97950197 T ES 97950197T ES 2196381 T3 ES2196381 T3 ES 2196381T3
- Authority
- ES
- Spain
- Prior art keywords
- gastrointestinal tract
- chupable
- tablets
- modified release
- active principles
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 210000001035 gastrointestinal tract Anatomy 0.000 title abstract 2
- 239000011248 coating agent Substances 0.000 abstract 3
- 238000000576 coating method Methods 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000007937 lozenge Substances 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 210000003296 saliva Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
SE DESCRIBE UNA TABLETA FARMACEUTICA PARA CHUPARSE CON LIBERACION MODIFICADA DE PRINCIPIOS ACTIVOS EN EL TRACTO GASTROINTESTINAL CON PARTICULAS QUE CONTIENEN LOS PRINCIPIOS ACTIVOS, LAS CUALES TIENEN UN PRIMER RECUBRIMIENTO QUE CONTROLA LA LIBERACION, Y UN SEGUNDO RECUBRIMIENTO EXTERNO CON PROPIEDADES RESISTENTES A LA SALIVA. EL PRIMER RECUBRIMIENTO, QUE CONTROLA LA LIBERACION DE LOS PRINCIPIOS ACTIVOS, PUEDE TENER PROPIEDADES DE RETARDAMIENTO O QUE SON RESISTENTES A LOS JUGOS GASTRICOS.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19648576A DE19648576C2 (de) | 1996-11-23 | 1996-11-23 | Lutschtablette zur modifizierten Freisetzung von Wirkstoffen im Gastrointestinaltrakt |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2196381T3 true ES2196381T3 (es) | 2003-12-16 |
Family
ID=7812582
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES97950197T Expired - Lifetime ES2196381T3 (es) | 1996-11-23 | 1997-11-17 | Comprimidos chupables para liberacion modificada de principios activos en el tracto gastrointestinal. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6270798B2 (es) |
| EP (1) | EP0941070B1 (es) |
| JP (1) | JP2001527526A (es) |
| KR (1) | KR100429489B1 (es) |
| AT (1) | ATE235232T1 (es) |
| AU (1) | AU725493B2 (es) |
| CA (1) | CA2272442C (es) |
| DE (2) | DE19648576C2 (es) |
| ES (1) | ES2196381T3 (es) |
| NO (1) | NO992477D0 (es) |
| WO (1) | WO1998023262A2 (es) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19849848A1 (de) * | 1998-10-29 | 2000-05-04 | Lohmann Therapie Syst Lts | Oral applizierbare, mit Flüssigkeit spontan zerfallende therapeutische Darreichungsform und Verfahren zu ihrer Herstellung |
| DE19933148A1 (de) * | 1999-07-20 | 2001-01-25 | Boehringer Ingelheim Int | Ambroxolhaltige Lutschtablette |
| US20060251722A1 (en) * | 2005-05-03 | 2006-11-09 | Novavax, Inc. | Multi-component vitamin and mineral supplement for the optimal absorption of components |
| AR077712A1 (es) | 2009-08-05 | 2011-09-14 | Idenix Pharmaceuticals Inc | Inhibidores de serina proteasa macrociclica |
| WO2011056764A1 (en) | 2009-11-05 | 2011-05-12 | Ambit Biosciences Corp. | Isotopically enriched or fluorinated imidazo[2,1-b][1,3]benzothiazoles |
| MY159958A (en) | 2009-12-18 | 2017-02-15 | Idenix Pharmaceuticals Inc | 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors |
| EP2557938B1 (en) * | 2010-01-15 | 2020-10-14 | Kemin Industries (Zhuhai) Co. Ltd. | Protected alpha-amylase |
| WO2011094890A1 (en) | 2010-02-02 | 2011-08-11 | Argusina Inc. | Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators |
| WO2011112689A2 (en) | 2010-03-11 | 2011-09-15 | Ambit Biosciences Corp. | Saltz of an indazolylpyrrolotriazine |
| US8703943B2 (en) | 2010-09-01 | 2014-04-22 | Ambit Biosciences Corporation | Optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof |
| MX2013002383A (es) | 2010-09-01 | 2013-07-05 | Ambit Biosciences Corp | Sales bromhidrato de una pirazolilaminoquinazolina. |
| JP2014500275A (ja) | 2010-12-06 | 2014-01-09 | フォリカ,インコーポレイテッド | 禿頭症を治療するため、および毛髪の成長を促進するための方法 |
| WO2012080050A1 (en) | 2010-12-14 | 2012-06-21 | F. Hoffmann-La Roche Ag | Solid forms of a phenoxybenzenesulfonyl compound |
| JP2014503597A (ja) | 2011-01-31 | 2014-02-13 | セルジーン コーポレイション | シチジンアナログの医薬組成物及びその使用方法 |
| TW201309690A (zh) | 2011-02-10 | 2013-03-01 | Idenix Pharmaceuticals Inc | 巨環絲胺酸蛋白酶抑制劑,其醫藥組合物及其於治療hcv感染之用途 |
| US20120252721A1 (en) | 2011-03-31 | 2012-10-04 | Idenix Pharmaceuticals, Inc. | Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor |
| CN104302640A (zh) | 2012-03-16 | 2015-01-21 | 埃克希金医药品有限公司 | 3,5-二氨基吡唑激酶抑制剂 |
| PT2833880T (pt) * | 2012-04-02 | 2017-12-06 | Pharma Seeds Create Llc | Composição de dosagem oral sólida de ibuprofeno compreendendo um copolímero de ácido metacrílico |
| NZ631142A (en) | 2013-09-18 | 2016-03-31 | Axikin Pharmaceuticals Inc | Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors |
| EP3046924A1 (en) | 2013-09-20 | 2016-07-27 | IDENIX Pharmaceuticals, Inc. | Hepatitis c virus inhibitors |
| US20150174079A1 (en) * | 2013-12-24 | 2015-06-25 | Food for Health International, LLC | Lozenges with silver nanoparticles |
| WO2015134560A1 (en) | 2014-03-05 | 2015-09-11 | Idenix Pharmaceuticals, Inc. | Solid forms of a flaviviridae virus inhibitor compound and salts thereof |
| IL291000B2 (en) | 2014-03-20 | 2024-04-01 | Capella Therapeutics Inc | Benzimidazole derivatives as erbb tyrosine kinase inhibitors for the treatment of cancer |
| CA2943231C (en) | 2014-03-20 | 2023-10-24 | Capella Therapeutics, Inc. | Benzimidazole derivatives as erbb tyrosine kinase inhibitors for the treatment of cancer |
| MY191736A (en) | 2014-12-23 | 2022-07-13 | Axikin Pharmaceuticals Inc | 3,5-diaminopyrazole kinase inhibitors |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2565107B1 (fr) * | 1984-05-30 | 1986-09-05 | Ucb Laboratoires | Nouveau medicament a base de charbon actif et son procede de preparation |
| DE3678641D1 (de) * | 1985-08-16 | 1991-05-16 | Procter & Gamble | Partikel mit konstanter wirkstofffreisetzung. |
| US4786508A (en) * | 1986-05-30 | 1988-11-22 | Warner-Lambert Company | Coated dosage forms |
| US4800087A (en) * | 1986-11-24 | 1989-01-24 | Mehta Atul M | Taste-masked pharmaceutical compositions |
| JPS63258809A (ja) * | 1987-04-16 | 1988-10-26 | Towa Yakuhin Kk | 医薬活性成分の放出性にすぐれ、かつ苦味を隠蔽した細粒剤 |
| JP2573969B2 (ja) * | 1987-10-21 | 1997-01-22 | 帝國製薬株式会社 | 薬物断続放出性口腔内適用製剤 |
| IT1256651B (it) * | 1992-12-11 | 1995-12-12 | Giancarlo Santus | Composizione farmaceutica a rilascio controllato in sospensione liquida |
| EP0524180B1 (en) * | 1990-04-11 | 1995-04-26 | The Upjohn Company | Taste masking of ibuprofen by fluid bed coating |
| IT1246383B (it) * | 1990-04-17 | 1994-11-18 | Eurand Int | Metodo per il mascheramento del sapore di farmaci |
| US5460825A (en) * | 1990-05-23 | 1995-10-24 | Mcneil-Ppc, Inc. | Taste mask coatings for preparing chewable pharmaceutical tablets |
| AU8219191A (en) * | 1990-06-14 | 1992-01-07 | Kalmo Enterprises, Inc. | Stable aqueous drug suspensions |
| US5464632C1 (en) * | 1991-07-22 | 2001-02-20 | Prographarm Lab | Rapidly disintegratable multiparticular tablet |
| WO1993024109A1 (en) * | 1992-06-04 | 1993-12-09 | Smithkline Beecham Corporation | Palatable pharmaceutical compositions |
| DE4333190C2 (de) * | 1993-09-29 | 1996-05-30 | Korsatko Werner Univ Prof Dr E | Zerbeißtablette mit verzögerter Wirkstoff-Freisetzung |
-
1996
- 1996-11-23 DE DE19648576A patent/DE19648576C2/de not_active Expired - Fee Related
-
1997
- 1997-11-17 AU AU53225/98A patent/AU725493B2/en not_active Ceased
- 1997-11-17 AT AT97950197T patent/ATE235232T1/de not_active IP Right Cessation
- 1997-11-17 JP JP52422698A patent/JP2001527526A/ja not_active Ceased
- 1997-11-17 CA CA002272442A patent/CA2272442C/en not_active Expired - Fee Related
- 1997-11-17 KR KR10-1999-7004537A patent/KR100429489B1/ko not_active Expired - Fee Related
- 1997-11-17 EP EP97950197A patent/EP0941070B1/de not_active Expired - Lifetime
- 1997-11-17 ES ES97950197T patent/ES2196381T3/es not_active Expired - Lifetime
- 1997-11-17 WO PCT/EP1997/006395 patent/WO1998023262A2/de not_active Ceased
- 1997-11-17 US US09/308,429 patent/US6270798B2/en not_active Expired - Fee Related
- 1997-11-17 DE DE59709645T patent/DE59709645D1/de not_active Expired - Fee Related
-
1999
- 1999-05-21 NO NO992477A patent/NO992477D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0941070A2 (de) | 1999-09-15 |
| US6270798B2 (en) | 2001-08-07 |
| NO992477L (no) | 1999-05-21 |
| DE19648576A1 (de) | 1998-06-04 |
| AU5322598A (en) | 1998-06-22 |
| KR100429489B1 (ko) | 2004-05-03 |
| AU725493B2 (en) | 2000-10-12 |
| US20010001668A1 (en) | 2001-05-24 |
| ATE235232T1 (de) | 2003-04-15 |
| NO992477D0 (no) | 1999-05-21 |
| DE19648576C2 (de) | 1999-08-12 |
| WO1998023262A3 (de) | 1998-09-11 |
| CA2272442C (en) | 2004-05-11 |
| KR20000057205A (ko) | 2000-09-15 |
| WO1998023262A2 (de) | 1998-06-04 |
| CA2272442A1 (en) | 1998-06-04 |
| JP2001527526A (ja) | 2001-12-25 |
| DE59709645D1 (de) | 2003-04-30 |
| EP0941070B1 (de) | 2003-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU5322598A (en) | Lozenge for the modified release of active compounds in the gastrointestinal tract | |
| AU7031500A (en) | Therapeutic quinazoline compounds | |
| YU36700A (sh) | Oralni farmaceutski oblik za doziranje sa produženim oslobađanjem | |
| FI973452L (fi) | Nauhoitettu annosmuoto aktiivisen aineen pidennettyyn jakamiseen | |
| MXPA03003895A (es) | Formulaciones de hidrocodona de liberacion controlada. | |
| BR9713237B1 (pt) | comprimido de liberaÇço controlada de cloridrato de alfuzosina e composiÇço farmacÊutica compreendendo o mesmo. | |
| NO2011009I1 (no) | Naproksen- og esomeprazoltabletter med modifisert frisetting | |
| AU5609998A (en) | Tablet for the controlled release of active agents | |
| DK0938316T3 (da) | Opioidantagonistholdig galenisk formulering | |
| CA2310585A1 (en) | Novel administration form comprising an acid-labile active compound | |
| NZ502445A (en) | Control of acidic gut syndrome | |
| MY133883A (en) | Gastrointestinal drug delivery system | |
| DE69925133D1 (de) | Pyrrolobenzodiazepine | |
| HUP0002744A3 (en) | Rapidly releasing and taste-masking pharmaceutical dosage form | |
| GB9025372D0 (en) | Pharmaceutical dosage forms | |
| DE69631609D1 (en) | Tricyclische erythromycinderivate | |
| IL139512A0 (en) | Oral medicinal preparations with reproducible release of the active ingredient gatifloaxacin or its pharmaceutically suitable salts or hydrates | |
| SE9201930D0 (sv) | Gastric antibacterial treatment | |
| DK0616802T3 (da) | Oralt præparat til frigivelse i de nedre fordøjelseskanaler | |
| ATE306910T1 (de) | Tablette mit verlängerter wirkstoffabgabe im magen | |
| AU4519399A (en) | Anti-inflammatory pharmaceutical formulations | |
| GB9907571D0 (en) | Compounds | |
| AU2773597A (en) | Pharmaceutical compositions for the sustained release of insoluble active principles | |
| FR2766088B1 (fr) | Dispositifs a liberation controlee d'un agent pharmaceutique, leur fabrication par co-extrusion et article intermediaire | |
| FI964885L (fi) | Hidastetusti mahanportin läpi kulkeutuva vaikuttavien aineiden kantaja vaikuttavien aineiden vapauttamiseksi säädellysti ruoansulatuskanavassa |